Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The drug is known generically as liraglutide, which the FDA says has been in short supply with certain other GLP-1 medications. This references the consistent shortages for drugs like semaglutides, known by brand names such as Ozempic and Wegovy, and tirzepatides, with brand names like Zepbound and Mounjaro
It is a pharmacological response to the drug and needs ongoing monitoring
Based on the literature available, most test subjects have no side effects, and those that do usually have minor side effects
[1] Serious adverse events should be reported to the FDA MedWatch program
Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action
It works best as a supportive supplement within an active lifestyle
